Since the beginning of this year, the profits of my country’s large-scale industrial enterprises have continued to grow, with high-tech manufacturing becoming the leading force driving stable growth in the manufacturing sector. In the capital market, companies represented by advanced manufacturing listed on the Shenzhen Stock Exchange have continued to perform well, and the foundation for high-quality development of enterprises in the machinery and equipment sub-sectors has been continuously strengthened.
High-end equipment shows strong resilience. Data shows that there are currently 489 advanced manufacturing companies listed on the Shenzhen Stock Exchange, with a market capitalization exceeding 5 trillion yuan. These companies achieved operating revenue exceeding 650 billion yuan and net profit of nearly 40 billion yuan in the first quarter of this year. In recent years, the high innovation, high penetration, and high driving force of advanced manufacturing have become increasingly prominent, making it an important area for my country’s implementation of the innovation-driven development strategy and a key link in ensuring the stability of the industrial chain and supply chain, smoothing the national economic cycle, and building a new development pattern.
Among them, high-end equipment manufacturing, situated at the core of the industrial chain, exhibits strong performance resilience, with the industry’s net profit increasing by 44% year-on-year. Hangzhou Oxygen Plant Group Co., Ltd. (Hangyang) aims to become a world-class enterprise in the gas industry, focusing on “strengthening and extending the industrial chain, and refining management” as its main work approach. It continuously strengthens its business foundation, builds a support system, accelerates transformation and upgrading, and overcomes various difficulties to achieve sustained growth in operating performance. As of the end of 2023, the company had been granted 577 patents. It led and participated in drafting 5 national standards and 6 industry standards, and released 15 group standards. The company continuously optimized its R&D structure, planned forward-looking R&D projects, and increased investment in scientific research. Simultaneously, the company strengthened the integration of production and research, enhanced cooperation with research institutes, and collaboratively tackled key problems, forming a high-quality innovation consortium. As a leading equipment manufacturing enterprise, Zoomlion delivered an impressive performance in 2023: achieving operating revenue of 47.075 billion yuan, a year-on-year increase of 13.08%; and net profit attributable to the parent company of 3.506 billion yuan, a year-on-year increase of 52.04%. Looking ahead to 2024, Zoomlion will focus on high-quality development goals, accelerating its transformation and upgrading towards digitalization, intelligence, and green manufacturing. It will also expedite the development of emerging business segments, further expand into overseas markets, cultivate and strengthen new growth poles and points, and continuously enhance its resilience and endogenous driving force, achieving a comprehensive improvement in sales scale, operational quality, and profitability. Jereh Group is a leading provider of high-end equipment and oil and gas engineering and oil and gas field technology services. The company stated that in the field of high-end equipment, some core components of key equipment have begun self-developed trial production and are being verified on-site. The medical device industry is accelerating its move towards high-end and intelligent manufacturing. As another representative sub-sector of advanced manufacturing, Shenzhen-listed medical device companies are continuously accelerating their progress towards high-end and intelligent manufacturing. Meiya Optoelectronics is one of the pioneers and leading companies in the domestic optoelectronic recognition field. Through years of continuous innovation and development, the company has successfully applied its recognition technology to multiple fields, with products covering industries including agricultural product testing, high-end medical imaging, and industrial inspection. In 2023, the company’s independently developed spinal surgery navigation device successfully obtained a medical device registration certificate, marking a breakthrough in the non-oral high-end medical imaging field. This device is suitable for the precise navigation and positioning of surgical instruments and implants during spinal surgery. It features an intelligent self-learning software system that continuously reduces the workload and increases efficiency for doctors through an efficient workflow, while reducing surgical risks and shortening the recovery period for patients. In February 2024, the company achieved another breakthrough in innovative research and development in the high-end medical imaging field. Its independently developed mobile head CT also obtained a medical device registration certificate issued by the National Medical Products Administration. This product further enriches the company’s medical product line and enhances its sustainable development capabilities. Meiya Optoelectronics’ high-end medical imaging equipment currently mainly includes dental X-ray CT diagnostic machines (dental CBCT), dental digital impression instruments (intraoral scanners), ear, nose, and throat CT, spinal surgery navigation equipment, and mobile head CT, etc. Among them, dental CBCT is widely used in various clinical applications such as dental implants, orthodontics, and endodontic treatment, and has many advantages such as high resolution, fast scanning speed, low radiation dose, good reconstruction effect, and high accuracy of 3D imaging. “Currently, dental CBCT has formed a multi-view imaging product lineup, which, combined with the latest intraoral scanners, can effectively meet the needs of various dental treatment clients,” revealed a relevant person in charge of Meiya Optoelectronics.
